Merit Medical Launches The FDA Cleared Micro ACE Advanced Micro-Access System
Merit Medical Launches The FDA Cleared Micro ACE Advanced Micro-Access System
Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced commercial release of its US Food and Drug Administration (FDA)-cleared Micro ACE Advanced Micro-Access System. Merit also intends to file Micro ACE for CE mark designation.
醫療保健技術的全球領導者Merit Medical Systems, Inc.（納斯達克股票代碼：MMSI）今天宣佈其經美國食品藥品監督管理局（FDA）批准的Micro ACE高級微訪問系統的商業發佈。Merit 還打算向 Micro ACE 申請 CE 標誌認證。
The Micro ACE system is the latest innovation in the Merit Vascular portfolio. The comprehensive portfolio includes a full range of percutaneous access and closure devices. Combining a balance of stiffness and resiliency, Micro ACE is designed to achieve micro-access in a wide range of vascular anatomies.
Micro ACE 系統是 Merit Vascular 產品組合中的最新創新。全面的產品組合包括全系列的經皮穿刺和封閉設備。Micro ACE 結合了剛度和彈性的平衡，旨在實現各種血管解剖結構的微接入。
Interventional procedures utilizing micro-access are commonly performed to diagnose and open narrowed (i.e., atherosclerotic) blood vessels. Atherosclerosis is an inflammatory condition that develops when there is a buildup of plaque inside the arteries. Diseases linked to atherosclerosis, such as coronary and peripheral artery disease, are the leading cause of death in the United States.1
使用微通道的介入手術通常用於診斷和打開狹窄（即動脈粥樣硬化）的血管。動脈粥樣硬化是一種炎症性疾病，當動脈內有斑塊積聚時就會發生。與動脈粥樣硬化相關的疾病，例如冠狀動脈和外周動脈疾病，是美國的主要死因。1
To facilitate such interventional procedures, the Micro ACE balances stiffness and flexibility to offer twice the resistance to kink and compression over the leading competitor. 2 It is also 9% stiffer than the leading standard micro-introducer. 2 In addition, a unique marker tip design allows for nine times greater visibility under fluoroscopy for accurate positioning needed at the start of a procedure.2 Merit is pursuing patents on Micro ACE technology in the United States and internationally.
爲了便於進行此類介入手術，Micro ACE平衡了剛度和靈活性，其抗扭結和壓縮能力是主要競爭對手的兩倍。2它的硬度也比領先的標準微型導入器高9％。2 此外，獨特的標記尖端設計可在透視下提高九倍的能見度，以實現手術開始時所需的精確定位。2 Merit 正在美國和國際上申請Micro ACE技術的專利。
Learn more about the Micro ACE.
了解有關 Micro ACE 的更多信息。
"Merit has always looked for opportunities to improve patient care. Micro ACE leverages our experience with reinforced sheath design to improve a procedure that is done over and over each day," said Fred P. Lampropoulos, Merit's Chairman and CEO. "We are excited to partner with interventional physicians to advance vascular access."
“Merit 一直在尋找改善患者護理的機會。Micro ACE利用我們在加固護套設計方面的經驗來改進每天反覆進行的手術。” Merit董事長兼首席執行官弗雷德·蘭普羅普洛斯說。“我們很高興能與介入醫生合作推進血管通路。”